Leigh C. Maier

Array ( [id] => 9363721 [patent_doc_number] => 20140073594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV' [patent_app_type] => utility [patent_app_number] => 14/080926 [patent_app_country] => US [patent_app_date] => 2013-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8368 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511909 [patent_doc_number] => 20140148400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/078455 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20108 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10387976 [patent_doc_number] => 20150272984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'AGENTS FOR THE PREVENTION AND/OR TREATMENT OF CENTRAL NERVOUS SYSTEM DAMAGE' [patent_app_type] => utility [patent_app_number] => 14/440005 [patent_app_country] => US [patent_app_date] => 2013-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19816 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757323 [patent_doc_number] => 20140288024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/063165 [patent_app_country] => US [patent_app_date] => 2013-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 129365 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14063165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757322 [patent_doc_number] => 20140288023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/061868 [patent_app_country] => US [patent_app_date] => 2013-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37496 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14061868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10411781 [patent_doc_number] => 20150296790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'SILICON-CONTAINING COMPOUND AQUEOUS SOLUTION AND ANTIBACTERIAL/ANTIVIRAL AGENT INCLUDING SAID SOLUTION' [patent_app_type] => utility [patent_app_number] => 14/437703 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11253 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9305995 [patent_doc_number] => 20140044669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/056554 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 37447 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9615738 [patent_doc_number] => 20140205594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/033815 [patent_app_country] => US [patent_app_date] => 2013-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 79023 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14033815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739229 [patent_doc_number] => 20140274947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/031533 [patent_app_country] => US [patent_app_date] => 2013-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 114799 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14031533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9384679 [patent_doc_number] => 20140088162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/025051 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8136 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18152021 [patent_doc_number] => 11564971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Hyaluronic acid derivative having amino acid and steryl group introduced thereinto [patent_app_type] => utility [patent_app_number] => 14/426485 [patent_app_country] => US [patent_app_date] => 2013-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 173 [patent_no_of_words] => 37475 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 349 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9832071 [patent_doc_number] => 08940888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Hydrazido derivatives of hyaluronic acid' [patent_app_type] => utility [patent_app_number] => 14/013454 [patent_app_country] => US [patent_app_date] => 2013-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7758 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10634505 [patent_doc_number] => 09351991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion' [patent_app_type] => utility [patent_app_number] => 13/969045 [patent_app_country] => US [patent_app_date] => 2013-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 4732 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13969045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10634502 [patent_doc_number] => 09351990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion' [patent_app_type] => utility [patent_app_number] => 13/969032 [patent_app_country] => US [patent_app_date] => 2013-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 4732 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13969032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634349 [patent_doc_number] => 20140212457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 13/965144 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10346 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538322 [patent_doc_number] => 20140162970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke With Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof' [patent_app_type] => utility [patent_app_number] => 13/961176 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5471 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325779 [patent_doc_number] => 20150210781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG' [patent_app_type] => utility [patent_app_number] => 14/416529 [patent_app_country] => US [patent_app_date] => 2013-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 43683 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10613788 [patent_doc_number] => 09333215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof' [patent_app_type] => utility [patent_app_number] => 13/941106 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11844 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307387 [patent_doc_number] => 20140046061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Processes Employing Cyclodextrin Derivative Quaternary Salts' [patent_app_type] => utility [patent_app_number] => 13/930420 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20219 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406696 [patent_doc_number] => 20150291705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'GLYCOL CHITOSAN DERIVATIVE HAVING HYDROPHOBIC SUBSTITUENT, METHOD FOR PREPARING SAME AND USE OF SAME' [patent_app_type] => utility [patent_app_number] => 14/438951 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7384 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438951 [rel_patent_id] =>[rel_patent_doc_number] =>)